drugset / Trial / NCT02606500

Efficacy of Corifollitropin Alfa in Obese Women in Terms of Clinical and Molecular Parameters of IVF Success

NCT02606500

Non-randomizedParallel-groupOpen-labelTreatment

Summary

The aim of the present study is to determine, whether clinical efficacy of 150 mcg of Corifollitropin alfa is the same in normal weighing and obese women. Furthermore, investigators want to determine whether oocytes retrieved from normal weighing and obese women, after COH using 150 mcg of Corifollitropin alfa, are of same quality on the molecular level.

Timeline

Start
2016-03
Primary completion
2017-01
Completion
2017-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Corifollitropin alfa Protein / enzyme biologic 100 ug Intramuscular
Subject Corifollitropin alfa Protein / enzyme biologic 150 ug Intramuscular

Indications